Valeant (VRX) options active after U.S. probe into potential defrauding of insurers

August 11, 2016 1:12 PM EDT

Find out which companies are about to raise their dividend well before the news hits the Street with StreetInsider.com's Dividend Insider Elite. Sign-up for a FREE trial here.

Valeant Pharma (NYSE: VRX) is recently down $2.51 to $24.80 after U.S. probe into potential defrauding of insurers. August weekly call option implied volatility is at 88, August is at 67, September is at 64; compared to its 52-week range of 34 to 175.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Options, Trader Talk

Related Entities

Options

Add Your Comment